ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
People Living with Familial Chylomicronaemia Syndrome (FCS) in Germany Have Access to REDEMPLO® (plozasiran) as a New Treatment Option to Reduce Triglycerides
Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy Back
Northern Trust Asset Management Brings Its FlexShares ETFs Under the Northern Trust Brand
WeTouch Technology Inc. Reports First Half Fiscal Year 2026 Financial Results